These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6604365)

  • 1. S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. I. Physicochemical and binding properties of S-sulfonated and reconstituted IgG.
    Gronski P; Hofstaetter T; Kanzy EJ; Lüben G; Seiler FR
    Vox Sang; 1983; 45(2):144-54. PubMed ID: 6604365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S-sulfonation: a reversible chemical modification of human immunoglobulins permitting intravenous application. II. Effect on Fc-mediated effector functions.
    Hofstaetter T; Gronski P; Kanzy EJ; Schorlemmer HU; Seiler FR
    Vox Sang; 1983; 45(2):155-65. PubMed ID: 6225247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual inhibition of the binding of Clq and protein A to rabbit IgG immune complexes.
    Laky M; Sjöquist J; Moraru I; Gheţie V
    Mol Immunol; 1985 Nov; 22(11):1297-302. PubMed ID: 3878459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cartilage proteoglycan interactions with C1q and the localization of aggregated IgG complexes in cartilage.
    Sparks K; Goetinck P; Ballow M
    Prog Clin Biol Res; 1982; 110 Pt B():113-23. PubMed ID: 6984760
    [No Abstract]   [Full Text] [Related]  

  • 5. On the mechanism of Clq binding to antibody-I. aggregation and/or distortion of IgG vs combining site-transmitted effects.
    Liberti PA; Bausch DM; Schoenberg LM
    Mol Immunol; 1982 Jan; 19(1):143-9. PubMed ID: 6176855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the role of tyrosine residues in human IgG and rabbit IgG in binding of complement subcomponent C1q.
    McCall MN; Easterbrook-Smith SB
    Biochem J; 1989 Feb; 257(3):845-51. PubMed ID: 2784672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C1 activation by immunoglobulin and immunoglobulin antibodies.
    Hughes-Jones NC; Feinstein A; Richardson NE; Gorick BD; Howard JC
    Biochem Soc Trans; 1984 Oct; 12(5):738-9. PubMed ID: 6333999
    [No Abstract]   [Full Text] [Related]  

  • 8. The complement subcomponent C1q mediates binding of immune complexes and aggregates to endothelial cells in vitro.
    Daha MR; Miltenburg AM; Hiemstra PS; Klar-Mohamad N; Van Es LA; Van Hinsbergh VW
    Eur J Immunol; 1988 May; 18(5):783-7. PubMed ID: 3259929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The presence of histidine residues at or near the C1q binding site of rabbit immunoglobulin G.
    McCall MN; Easterbrook-Smith SB
    Biochim Biophys Acta; 1987 Mar; 912(1):9-15. PubMed ID: 3493808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of Clq binding activity by IgM rheumatoid factor.
    Zilberfarb JL; Andrews BS; Young AC; Davis JS
    J Rheumatol; 1985 Jun; 12(3):444-8. PubMed ID: 3876433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological parameters in subjects with essential arterial hypertension. II. Serological observations].
    Obbiassi M; Bigi G; Cancellieri V; Palmieri G; Morganti A; Tempesti P; Lettino M
    Boll Ist Sieroter Milan; 1982; 61(6):494-8. PubMed ID: 6985421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum and plasma fibronectin binds to complement reacted immune complexes primarily via Clq.
    Baatrup G; Svehag SE
    Scand J Immunol; 1986 Nov; 24(5):583-90. PubMed ID: 3097811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of the binding of C1q to immune complexes by zinc.
    Easterbrook-Smith SB
    FEBS Lett; 1983 Oct; 162(1):117-9. PubMed ID: 6604665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cleavage of the inter-chain disulphide bonds of rabbit IgG on its ability to bind C1q.
    Sutton J; Alden JR; Easterbrook-Smith SB
    Biochim Biophys Acta; 1984 May; 787(1):39-44. PubMed ID: 6609719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of TNP-conjugated polyacrylamide beads in a C1q binding inhibition test for circulating immune complexes.
    Schmidt R; Walther S; Sodomann CP
    Immunobiology; 1982; 162(2):153-64. PubMed ID: 6981581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating immune complexes in patients with glomerulonephritis and in renal transplant patients.
    Sølling J
    Scand J Urol Nephrol Suppl; 1985; 97():1-46. PubMed ID: 3915401
    [No Abstract]   [Full Text] [Related]  

  • 17. Circulating antigen-antibody complexes in onchocerciasis.
    Steward MW; Sisley B; Mackenzie CD; El Sheikh H
    Clin Exp Immunol; 1982 Apr; 48(1):17-24. PubMed ID: 6979445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative studies on biological activities of subcomponents C1q of the first component of human, bovine, mouse and guinea-pig complement.
    Sasaki T; Yonemasu K
    Biochim Biophys Acta; 1984 Mar; 785(3):118-22. PubMed ID: 6608375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement interaction with immune serum globulin and immune globulin intravenous.
    Bing DH
    Am J Med; 1984 Mar; 76(3A):19-24. PubMed ID: 6424450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo reduction of circulating C1q binding immune complexes by intravenous gammaglobulin administration.
    Lin RY; Racis SP
    Int Arch Allergy Appl Immunol; 1986; 79(3):286-90. PubMed ID: 2419257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.